Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Jun 2026 for Biomarin Pharmaceutical INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark J. Enyedy: trading record in brief
Mark J. Enyedy, listed as chief executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in ImmunoGen, Inc., Biomarin Pharmaceutical Inc and Charles River Laboratories International, Inc. The record holds 12 filings, for trades running from 30 June 2021 to 2 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 4 June 2026, the filings show a share grant in Biomarin Pharmaceutical Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark J. Enyedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
7,490 shares0Common StockSEC:0001628280-26-040914:0
946 shares@ US$135.04100.0% of flowCommon StockSEC:0001127602-25-016729:0
6,650 shares0Common StockSEC:0001048477-25-000070:0
4,720 shares0Common StockSEC:0001048477-24-000100:0
584,397 sharesCommon StockSEC:0001104659-24-014715:0
51,234 shares0Common StockSEC:0001415889-24-002871:0
2,180 shares0Common StockSEC:0001048477-23-000072:0
995,157 shares@ US$4.5598.4% of flowCommon StockSEC:0001415889-23-011881:0
5,241 shares@ US$4.050.5% of flowCommon StockSEC:0001415889-23-010830:0
2,921 sharesCommon StockSEC:0000899243-22-036305:0
3,342 shares@ US$3.8250.3% of flowCommon StockSEC:0001415889-22-007327:0
3,849 shares@ US$5.520.4% of flowCommon StockSEC:0001179110-21-007317:0
12 of 12 declarations
